Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China

por Hu, Shanshan, Wang, Shuowen, Qi, Chendong, Gu, Shengying, Shi, Chenyang, Mao, Lin, Fan, Guorong
Publicado 2022

Robust Prediction of Prognosis and Immunotherapy Response for Bladder Cancer through Machine Learning Algorithm

por Hu, Shanshan, Gu, Shengying, Wang, Shuowen, Qi, Chendong, Shi, Chenyang, Qian, Fengdan, Fan, Guorong
Publicado 2022